Ascent Group LLC Raises Stock Holdings in Intuitive Surgical, Inc. $ISRG

Ascent Group LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 86.1% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,358 shares of the medical equipment provider’s stock after acquiring an additional 5,256 shares during the quarter. Ascent Group LLC’s holdings in Intuitive Surgical were worth $6,172,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of ISRG. Brighton Jones LLC increased its position in shares of Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the last quarter. NBC Securities Inc. purchased a new stake in Intuitive Surgical in the first quarter worth $135,000. Thurston Springer Miller Herd & Titak Inc. increased its position in Intuitive Surgical by 19.8% in the first quarter. Thurston Springer Miller Herd & Titak Inc. now owns 2,292 shares of the medical equipment provider’s stock worth $1,135,000 after buying an additional 379 shares during the last quarter. Vest Financial LLC increased its position in Intuitive Surgical by 73.5% in the first quarter. Vest Financial LLC now owns 4,728 shares of the medical equipment provider’s stock worth $2,342,000 after buying an additional 2,003 shares during the last quarter. Finally, Signal Advisors Wealth LLC increased its position in Intuitive Surgical by 12.9% in the first quarter. Signal Advisors Wealth LLC now owns 1,800 shares of the medical equipment provider’s stock worth $891,000 after buying an additional 206 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $452.35 on Friday. The firm has a market capitalization of $162.16 billion, a P/E ratio of 63.09, a PEG ratio of 4.64 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The business has a fifty day moving average price of $463.55 and a 200-day moving average price of $500.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm’s quarterly revenue was up 21.4% on a year-over-year basis. During the same quarter last year, the company earned $1.78 earnings per share. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 4,500 shares of Intuitive Surgical stock in a transaction on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares of the company’s stock, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director directly owned 739 shares of the company’s stock, valued at $325,669.91. This represents a 31.19% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 45,224 shares of company stock valued at $21,716,492. Company insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Royal Bank Of Canada reissued an “outperform” rating and issued a $615.00 target price on shares of Intuitive Surgical in a research report on Tuesday, August 19th. UBS Group raised their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 23rd. BTIG Research reissued a “buy” rating and issued a $571.00 target price on shares of Intuitive Surgical in a research report on Wednesday. Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Zacks Research downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, August 20th. Fourteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $594.19.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.